Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11781135 Methods for treating Alzheimer's disease

Overview Structured Data Issues Contributors Activity

Is a

Patent

Date Filed

March 11, 2019

Date of Patent

October 10, 2023

Patent Application Number

16298607

Patent Citations

‌

US Patent 7750131 5′-modified bicyclic nucleic acid analogs

‌

US Patent 8153365 Oligonucleotide analogues

‌

US Patent 8178503 Ribonucleic acid interference molecules and binding sites derived by analyzing intergenic and intronic regions of genomes

‌

US Patent 8268980 5′-modified bicyclic nucleic acid analogs

‌

US Patent 8278283 6-disubstituted or unsaturated bicyclic nucleic acid analogs

‌

US Patent 8278425 None

‌

US Patent 8278426 Carbocyclic bicyclic nucleic acid analogs

‌

US Patent 8329890 SiRNA-mediated gene silencing

‌

US Patent 8440803 Tetrahydropyran nucleic acid analogs

‌

US Patent 8501805 Substituted alpha-L-bicyclic nucleosides

•••

Patent Citations Received

‌

US Patent 12091662 Compositions for modulating tau expression

Patent Inventor Names

Timothy M. Miller

Sarah Devos

Frank Rigo

C. Frank Bennett

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11781135

Patent Primary Examiner

CPC Code

•••

Find more entities like US Patent 11781135 Methods for treating Alzheimer's disease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API